Bayer's Cell, Gene Therapies for Parkinson's Disease Enters Human Trials

[Farooqji]

Bayer’s subsidiary BlueRock Therapeutics’s trial will eventually enroll 10 participants. Patients will have dopamine-producing cells surgically implanted into a part of the brain called the putamen.

m.benzinga.com/article/2147...

[jeffreyn]

Study record for the iPSC trial:

Phase 1 Safety and Tolerability Study of MSK-DA01 Cell Therapy for Advanced Parkinson's Disease - Full Text View - ClinicalTrials.gov

clinicaltrials.gov/ct2/show...

Study record for the gene therapy trial:

GDNF Gene Therapy for Parkinson's Disease - Full Text View - ClinicalTrials.gov

clinicaltrials.gov/ct2/show...

Both trials are currently recruiting PwPs.